Ultragenyx Pharmaceutical | Attività Correnti



Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Insmed USD 1.4B 218.97M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Kyowa Hakko Kirin JPY 450.23B 53.79B 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.64B 86.8M 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12


Ultragenyx Pharmaceutical Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.